Lv1
40 积分 2024-04-16 加入
Development of a Scalable Process for an IL-17A Inhibitor LY3509754. Part II: Synthesis of the α-Bromoketone Intermediate Leveraging Concomitant Decarboxylation Following Enzymatic Ester Hydrolysis
15天前
已完结
Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control
15天前
已完结
Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate
15天前
已完结
Kilo-Scale-Enabled Route toward PF-07907063, a Type II Brain Penetrant cMET Inhibitor
18天前
已完结
Development of a Convergent and Scalable Synthetic Route to Long-Acting RSV Inhibitor JNJ-7950
1个月前
已完结
Process Development toward the Continuous Manufacturing of Baloxavir Marboxil
1个月前
已完结
Novel and Cost-Effective Manufacturing Process Development of Daprodustat
1个月前
已完结
Process Development toward the Continuous Manufacturing of Baloxavir Marboxil
1个月前
已完结
Some Issues and Their Solutions in the Process Development of Ethyl 2-(4-Aminophenoxy)thiazole-5-carboxylate: A Key Intermediate of P2X3 Antagonist
1个月前
已完结
Development of a Scalable Synthesis of Casdatifan (AB521), a Potent, Selective, Clinical-Stage Inhibitor of HIF-2α
2个月前
已完结
皖公网安备34019202002308
